CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study
Por:
Carriel J, Muñoz-Jaramillo R, Bolaños-Ladinez O, Heredia-Villacreses F, Menéndez-Sanchón J, Martin-Delgado J and en representación del grupo de investigadores COVID-EC
Publicada:
1 ene 2022
Ahead of Print:
1 dic 2021
Categoría:
Medicine (miscellaneous)
Resumen:
Objective: This article aims to assess the utility of CURB-65 in predicting 30-day mortality in adult patients hospitalized with COVID-19.
Methods: This work is a cohort study conducted between March 1 and April 30, 2020 in Ecuador.
Results: A total of 247 patients were included (mean age 60 +/- 14 years, 70% men, overall mortality 41.3%). Patients with CURB-65 >= 2 had a higher mortality rate (57 vs. 17%, p < .001) that was associated with other markers of risk: advanced age, hypertension, overweight/obesity, kidney failure, hypoxemia, requirement for mechanical ventilation, or onset of respiratory distress.
Conclusions: CURB-65 >= 2 was associated with higher 30-day mortality on the univariate (Kaplan-Meier estimator) and multivariate (Cox regression) analysis. (C) 2020 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
Green Published
FULL TEXT
 |
Published Version |
This policy does not allow for Open Access for this version |
| No Accesible |
|